Robert L. Scavo Net Worth
Track Major Insider Updates On X/TwitterLast Updated: 5 days, 22 hours ago
Robert L. Scavo has an estimated net worth of at least $11.0 million*, as of June 25, 2025. They own 602,090 shares of ALHC stock. They have sold 185,351 shares of ALHC stock since 2021, for an estimated $2.7 million.
Robert L. Scavo $ALHC SEC Form 4 Insider Trading
Robert L. Scavo has filed a total of 12 insider trades in $ALHC since 2021. Their most recent trade was a sale of 40,863 shares, made on Jun 11, 2025. Their largest trade was a sale of 60,000 shares, made on Jun 10, 2025. We estimate that they now own 602,090 shares of $ALHC, worth an estimated $8.3 million.
Insider Trading at $ALHC
There have been a total of 277 insider trades reported at $ALHC since 2021, with 203,000 shares purchased and 86.3 million shares sold. The most active insider traders in $ALHC stock have been Robert Thomas Freeman, John E Kao, and Dawn Christine Maroney. The most recent trade was a sale of 90,000 shares reported by JOHN E KAO (Chief Executive Officer), made on Jun 16, 2025.
History of Insider Stock Trades by Robert L. Scavo
| Company Ticker | Purchase / Sale | Shares | Date | Disclosed (EST) |
|---|---|---|---|---|
ALHC
|
Sale | 40,863 | Jun 11, 2025 | June 12, 2025, 5:47 p.m. |
|
ALHC
|
Sale | 60,000 | Jun 10, 2025 | June 12, 2025, 5:47 p.m. |
|
ALHC
|
Sale | 2,864 | Mar 27, 2025 | March 28, 2025, 8:30 p.m. |
|
ALHC
|
Sale | 3,923 | Mar 18, 2025 | March 19, 2025, 9:54 p.m. |
|
ALHC
|
Sale | 4,634 | Mar 19, 2025 | March 19, 2025, 9:54 p.m. |
|
ALHC
|
Sale | 2,600 | Mar 19, 2025 | March 19, 2025, 9:54 p.m. |
|
ALHC
|
Sale | 75 | Mar 12, 2025 | March 13, 2025, 5:07 p.m. |
|
ALHC
|
Sale | 5,238 | Mar 12, 2025 | March 13, 2025, 5:07 p.m. |
|
ALHC
|
Sale | 55,403 | Mar 06, 2025 | March 6, 2025, 8:35 p.m. |
|
ALHC
|
Sale | 1,821 | Mar 28, 2024 | March 29, 2024, 8 p.m. |
|
ALHC
|
Sale | 3,078 | Mar 19, 2024 | March 21, 2024, 5 p.m. |
|
ALHC
|
Sale | 4,852 | Mar 15, 2024 | March 15, 2024, 8 p.m. |
$ALHC Executives and Stock Owners with Insider Trades
-
Robert Thomas Freeman, Chief Financial Officer
-
John E Kao, Chief Executive Officer
-
Dawn Christine Maroney, President, Markets
-
Dinesh M. Kumar, Chief Med & Operating Officer
-
Christopher J Joyce, Chief Legal and Admin. Officer
-
Hakan Kardes, Chief Experience Officer
-
Dawn Christine Maroney, President
-
Robert L. Scavo, Chief Information Officer
-
Hyong Kim, Chief Medical Officer
-
Andreas P. Wagner, Chief Human Resources Officer
-
Dinesh M. Kumar, Chief Medical Officer
-
Joseph S Konowiecki, Chairman of the Board
-
Richard A. Cross, SVP, General Counsel
-
Sebastian Burzacchi, COO - Mgmt Services Org
-
Donald Steven Furman, Chief Clinical Officer
-
Rajesh Shrestha, Pres., New Markets & CBO
*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.